You are here
Innovax®-ND-ILT concentrate and solvent for suspension for injection for chickens
Innovax-ND-ILT provides effective 3 in 1 protection against Marek's Disease, Newcastle Disease and Infectious Laryngotracheitis.
Presentation
Off-red to red concentrate and clear red solution as solvent for suspension for injection.
Active ingredients
Each dose of reconstituted vaccine (0.2 ml for subcutaneous use or 0.05 ml for in ovo use) contains:
Active substance: Cell associated live recombinant turkey herpesvirus (strain HVT/NDV/ILT), expressing the fusion protein of Newcastle disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus: 103.3 - 104.3 PFU*. *PFU - plaque forming units.
Target species
Chickens and embryonated chicken eggs.
Indications for use
For active immunisation of one-day old chicks or 18-19 day-old embryonated chicken eggs:
- to reduce mortality and clinical signs caused by Newcastle disease (ND) virus
- to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ILT) virus and Marek's disease (MD) virus
Onset of immunity: ND: 5 weeks of age, ILT: 4 weeks of age MD: 9 days. Duration of immunity: ND: 62 weeks, ILT: 62 weeks, MD: entire risk period.
Withdrawal periods
Poultry - meat 0 days
Packaging
Cell concentrate: Type 1 glass ampoule of 2 ml containing 2,000 or 4,000 doses. Ampoules are stored on a cane and attached to the cane is a coloured clip displaying the dose (2,000 doses: salmon-pink coloured clip, and 4,000 doses: yellow coloured clip).
Solvent:
- 400 ml multilayer plastic bag.
- 800 ml multilayer plastic bag.
Not all pack sizes may be marketed.
Legal category
POM-V
For full information please refer to the product data sheet. Further information is available on request.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Use Medicines Responsibly.
Date of preparation: June 2021
References
Innovax®-ND-ILT contains cell-associated live recombinant turkey herpesvirus (strain HVT/NDV/ILT), expressing the fusion protein of Newcastle disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus: 103.3 – 104.3 PFU. POM-V. Nobilis® Rismavac contains live cell associated Marek’s disease virus strain CVI988 ≥ 3.0 log10 TCID50. POM-VPS.
Further information is available from the SPC, datasheet or package leaflet. MSD Animal Health UK Ltd. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942. Advice should be sought from the medicine prescriber.
Use Medicines Responsibly.